Journalists Describe Drivers of High Health Costs and Spell Out the Science of Protein
KFF Health News senior correspondent Renuka Rayasam discussed concerns about health care costs following the…
KFF Health News senior correspondent Renuka Rayasam discussed concerns about health care costs following the expiration of enhanced Affordable Care Act tax credits on CBS News’ CBS News 24/7 on Feb. 5. Rayasam also discussed rising health insurance costs on WUGA’s The Georgia Health Report on Jan. 30. Click here to watch Rayasam on CBS…
HHS is scrapping its proposed 340B rebate pilot after hospitals sued to stop it. Providers say the plan would have created cash flow problems and administrative burdens that threatened safety-net care. The post Why HHS Scrapping Its 340B Rebate Program Is a Win For Providers appeared first on MedCity News.
As Gov. Gavin Newsom spars with President Donald Trump and courts national attention for a potential presidential bid, at home he’s catching flak from the left and the right on health care. The California Democrat came into office promising to fight for “guaranteed health care for all,” and he came close to achieving it. Really close. But as it turns out, that’s easier said than done when you’re juggling chronic budget deficits, rising health care costs, and shrinking federal support. Now he’s walking…
Chamber’s Series A round was led by Frist Cressey Ventures, with participation from General Catalyst, AlleyCorp, American Family Ventures, Company Ventures, Optum Ventures, Healthworx Ventures and Black Opal Ventures. The post Chamber Secures $60M to Advance Value-Based Cardiology appeared first on MedCity News.
That is the title of a paper I published today in Journal of Market Access & Health Policy with co-authors by Karim EI-Kersh, Nadine Zawadzki, Catelyn Coyle, Shurui Zhang, Dhruv Dalal, Anna Watzker, and Dominik Lautsch. The abstract is below: Pulmonary arterial hypertension (PAH) and cancer share high mortality and complex prognoses. Due to PAH’s…
Bayer’s asundexian, a Factor XIa inhibitor, reduced the risk of secondary stroke by 26% without increasing bleeding risk in a Phase 3 clinical trial. The once-daily pill is at the front of an emerging class of medicines that includes drug candidates from Regeneron Pharmaceuticals and partners Bristol Myers Squibb and Johnson & Johnson. The post…
This issue brief explains why it can be misleading to compare the first year of Rural Health Transformation Program allocations with estimated Medicaid cuts, which will be implemented on a gradual basis and not fully take effect until 2027, after the rural health fund is exhausted.
La decisión del gobierno de Trump de dar a funcionarios encargados de deportaciones acceso a los datos de Medicaid está poniendo a los hospitales y a estados en un aprieto, ya que deben decidir si advierten a sus pacientes inmigrantes que toda su información personal, incluida la dirección de su casa, podría utilizarse para expulsarlos…
When AI is honest and acts as a connector in healthcare workflows, clinician time is freed up, accuracy is ensured, and revenue is protected. The post Keeping Honest in Healthcare: Engineering Accountability into AI appeared first on MedCity News.